Unified Patents, LLC
Membership organization designed to deter assertion of bad patents.
Based in MD
🤖
AI Overview
With $265K in lobbying spend across 12 quarterly filings, Unified Patents, LLC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2025.
$265K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $105K |
| 2024 | $80K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent
- •Issues relating to the deterrence of assertion of bad patents, preservation of access to the Patent Trial and Appeal Board at the USPTO, and regulatory attempts to weaken the America Invents Act of 20
- •Issues related to the Patent Trial and Appeals Board, including both legislative and regulatory proposals. S. 2220
- •Issues related to the rules governing the Patent Trial and Appeals Board, including both legislative and regulatory proposals. S. 2220, the PREVAIL Act
Related Analysis
Related Investigations
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Association for Molecular Pathology
$1.5M total spend
Otsuka Pharmaceutical Development & Commercialization, INC.
$300K total spend
Gorman Strategy Group, Too on Behalf of Parkervision, INC.
$140K total spend
Stanton Park Group LLC on Behalf of Intuit, INC. and Affiliates
$90K total spend
American Beverage Licensees
$0 total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.